Laure Morin‐Papunen

Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome

Terhi Piltonen, Laure Morin‐Papunen, Riitta Koivunen et al. · Human Reproduction · 2005 · 308 citations

Medicine, Endocrinology, Gynecology +14

Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndrome

Laure Morin‐Papunen, Riitta Koivunen, Aimo Ruokonen et al. · Fertility and Sterility · 1998 · 295 citations

Medicine, Endocrinology, Pharmacotherapy +17

Metformin Reduces Serum C-Reactive Protein Levels in Women with Polycystic Ovary Syndrome

Laure Morin‐Papunen, K Rautio, Aimo Ruokonen et al. · The Journal of Clinical Endocrinology & Metabolism · 2003 · 247 citations · Full text

Medicine, Endocrinology, Inflammation +16

Metformin Improves Pregnancy and Live-Birth Rates in Women with Polycystic Ovary Syndrome (PCOS): A Multicenter, Double-Blind, Placebo-Controlled Randomized Trial

Laure Morin‐Papunen, Anni S. Rantala, Leila Unkila‐Kallio et al. · The Journal of Clinical Endocrinology & Metabolism · 2012 · 239 citations · Full text

Medicine, Endocrinology, Gynecology +15

Endocrine and Metabolic Effects of Metformin<i>Versus</i>Ethinyl Estradiol-Cyproterone Acetate in Obese Women with Polycystic Ovary Syndrome: A Randomized Study¹

Laure Morin‐Papunen, Ilkka Vauhkonen, Riitta Koivunen et al. · The Journal of Clinical Endocrinology & Metabolism · 2000 · 235 citations · Full text

Medicine, Endocrinology, Pharmacology +17